Moreover, subsequent studies have shown a significant reduction in the risk to develop PD in those IBD patients that received early treatments with anti-inflammatory therapies such as anti-TNF-α or underwent surgery where tissue with high concentrations of α-synuclein aggregates was removed, thus limiting Lewy bodies spreading to the brain (25, 26). The gene discussed is TNF; the disease is Parkinson disease.